Literature DB >> 29515003

Type 2 diabetes mellitus severity correlates with risk of hip fracture in patients with osteoporosis.

J-Y Hsu1, C-Y Cheng, C-Y Hsu.   

Abstract

BACKGROUND: Osteoporosis is a major public health problem because of its associated fractures and the resulting complications. The objective of this study was to identify the association between the severity of type 2 diabetes mellitus (T2DM) and the risk of hip fracture in osteoporotic patients.
METHODS: The patients who received a diagnosis of osteoporosis between 2006 and 2010, with an adequate follow-up between 2006 and 2015, were enrolled in this study. Among patients with T2DM, the severity of the disease was evaluated using the Diabetes Complication Severity Index (DCSI). Logistic regression models were used to calculate the odds ratios and to predict the risk of hip fracture in diabetic osteoporotic patients.
RESULTS: A total of 1188 patients were enrolled in the final study, 87 patients had hip fractures in the follow-up period between 2006 and 2015. Among the diabetic patients, each level of the continuous DCSI was associated with a 1.56-fold greater risk of hip fracture. In further stratification, patients with a DCSI > 3 had a significantly higher risk of hip fracture in comparison with those with a DCSI ≤ 1. The categorical DCSI (DCSI > 3), HbA1c level on the diagnosis of T2DM and duration of diabetes, facilitate predicting the risk of hip fracture.
CONCLUSION: The severity of T2DM reflects the risk of hip fracture in osteoporotic patients. Physicians should pay attention to osteoporotic patients presenting with a high HbA1c level on diagnosis of T2DM and a higher DCSI because of their vulnerability to hip fracture.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29515003

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  5 in total

1.  Correlation Between Serum 25(OH)D and Abdominal Visceral Fat Area in Patients with Type 2 Diabetes Mellitus in the Context of different Bone Mass.

Authors:  Q Li; Y Zhao; Y P Wang; Y Yang; S M He; X Zhang; Z Wang; L Y Luo
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 1.104

2.  Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus.

Authors:  Dan Liu; Jing-Jie Bai; Jun-Jie Yao; Yong-Bo Wang; Tong Chen; Qian Xing; Ran Bai
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-29       Impact factor: 3.168

3.  Determination of risk factors of postoperative pneumonia in elderly patients with hip fracture: What can we do?

Authors:  Yibing Yu; Peiwen Zheng
Journal:  PLoS One       Date:  2022-08-23       Impact factor: 3.752

4.  The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus.

Authors:  Cindy Sarodnik; Nicklas H Rasmussen; Sandrine P G Bours; Nicolaas C Schaper; Peter Vestergaard; Patrick C Souverein; Morten H Jensen; Johanna H M Driessen; Joop P W van den Bergh
Journal:  Bone Rep       Date:  2022-08-22

5.  Impact of type 2 diabetes on postoperative outcome after hip fracture: nationwide population-based study in Taiwan.

Authors:  Tien-Ching Lee; Yu-Li Lee; Jian-Chih Chen; Chung-Hwan Chen; Pei-Shan Ho
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.